Jun 28, 2024, 13:32
Updated results from the TRANSMET trial at ESMOGI24
ESMO shared on X:
“ESMOGI24: Updated results from the TRANSMET trial showed that chemotherapy combined with liver transplantation in highly selected patients with CRC quadrupled the 5-year OS rate VS chemotherapy alone.
Link to ESMO Daily Reporter.”
Source: ESMO/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 22:40
Dec 21, 2024, 22:37
Dec 21, 2024, 22:26